Novo Nordisk’s shares rose by more than 16% on Tuesday, as the results of the trial exceeded investor expectations.
Weight-Loss Drug Wegovy Lowers Major Heart Disease Risk By 20%, Trial Says—Novo Nordisk Shares Surge
Novo Nordisk’s shares rose by more than 16% on Tuesday, as the results of the trial exceeded investor expectations.